Insider Selling: Firefly Neuroscience (NASDAQ:AIFF) Major Shareholder Sells $106,368.35 in Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 40,139 shares of the stock in a transaction that occurred on Thursday, October 16th. The stock was sold at an average price of $2.65, for a total transaction of $106,368.35. Following the sale, the insider directly owned 1,412,562 shares of the company’s stock, valued at approximately $3,743,289.30. This trade represents a 2.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Friday, October 17th, Windsor Private Capital Lp sold 45,036 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.55, for a total value of $114,841.80.
• On Wednesday, October 15th, Windsor Private Capital Lp sold 17,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total value of $47,950.00.
• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total value of $80,830.00.
• On Monday, October 13th, Windsor Private Capital Lp sold 32,136 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.65, for a total value of $85,160.40.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.70, for a total value of $201,987.00.
• On Thursday, October 9th, Windsor Private Capital Lp sold 30,126 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.94, for a total value of $88,570.44.

Firefly Neuroscience Stock Performance

Shares of AIFF opened at $2.51 on Monday. The firm has a market capitalization of $33.76 million, a price-to-earnings ratio of -1.00 and a beta of 2.11. Firefly Neuroscience, Inc. has a one year low of $1.86 and a one year high of $17.20. The stock’s fifty day moving average is $2.78 and its 200-day moving average is $2.97.

Firefly Neuroscience (NASDAQ:AIFF) last announced its earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share for the quarter. Firefly Neuroscience had a negative net margin of 5,335.75% and a negative return on equity of 464.02%.

Institutional Investors Weigh In On Firefly Neuroscience

A hedge fund recently raised its stake in Firefly Neuroscience stock. Geode Capital Management LLC lifted its stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 120,604 shares of the company’s stock after acquiring an additional 58,067 shares during the period. Geode Capital Management LLC owned 0.94% of Firefly Neuroscience worth $341,000 at the end of the most recent reporting period. 4.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Firefly Neuroscience in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Firefly Neuroscience has a consensus rating of “Sell”.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.